Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
about
Screening for Anal Cancer in WomenHigh prevalence of HPV in non-cervical sites of women with abnormal cervical cytology.Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years.Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada.Anal intraepithelial neoplasia: A review of diagnosis and managementAnal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women.Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence.Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.Human papillomavirus-associated oropharyngeal squamous cell carcinoma and anogenital cancers in men: Epidemiologic evaluation of association.Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.Anal Cancer and Anal Cancer precursors in Women with a History of HPV-Related Dysplasia and Cancer.Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
P2860
Q28085226-0256C224-614E-48BB-9DB1-26FA6DEE4007Q34065359-EA79FBDE-E06D-4CC3-859A-4F24E982D7A1Q35583349-F9B93F73-2E65-4C12-9B4A-B729072A416CQ35677952-568EC513-BF19-471E-8CAD-BF884A43A8C7Q36062717-6A9DB8ED-CD62-4932-B877-43157D74C211Q36296115-610040EA-1C08-4D11-B422-5FEFB92B2E92Q36904132-8F545E21-7ECC-48EF-BB1F-3E5F6843997FQ36927578-0065BBB5-9C33-419F-A306-E43EAAB9B1F2Q37176188-F7330C97-6B6D-445A-80E4-6CF700BB3D4DQ37604535-94A9F5C6-C657-43A6-83FB-4E73A9DC389CQ38134426-65729C1C-71F9-43ED-8349-564C8303D983Q38341743-AABC3944-BCFF-4ACF-AD43-02B0659C60C7Q40019997-C29F37D8-6B79-4B00-B755-C2D3A58061DAQ45960889-E6198535-1B20-4246-93C3-B7F2DB8890FCQ47801255-03B3D1B8-AFC7-4772-98AD-7DD7BE632426Q52905730-089F6635-D801-4464-B410-8E73E5AA17B0
P2860
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@ast
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@en
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@nl
type
label
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@ast
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@en
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@nl
prefLabel
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@ast
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@en
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@nl
P2093
P1476
Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
@en
P2093
Abdulaziz M Saleem
Anne P Shapter
Jessica K Paulus
Patricia L Roberts
Rocco Ricciardi
P304
P356
10.1097/AOG.0B013E31820BFB16
P407
P50
P577
2011-03-01T00:00:00Z